CUTNETs aims to improve surgical evidence for NETs by identifying high-risk patients and developing resectability criteria. Collaboration is essential due to the uncommon nature of NETs and the need ...
Steve Jobs succumbed to a rare pancreatic neuroendocrine tumor. This cancer type differs significantly from common pancreatic ...
MIAMI, FLORIDA (April 30, 2024) – Newly updated guidelines on neuroendocrine tumors developed by an expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine ...
3h
Crinetics Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Launched in the U.S. with Encouraging Early Feedback from Patients and Physicians, and Positive Reimbursement Trends ...
Rachael Guenter, Ph.D., an assistant professor in the Division of Surgical Oncology in the UAB Department of Surgery, was recently featured in The Endocrinologist, the Society for Endocrinology’s ...
Preliminary analysis of one-year progression-free survival data from Phase 2 study of novel SST2 agonist paltusotine under ...
Pharmaceuticals announced three abstracts from its clinical development programs will be presented at the upcoming North American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback